Genotypic and Clinical Features of Human Metapneumovirus Infections in Hospitalized Children With Acute Respiratory Infections
DOI:
https://doi.org/10.46966/msjar.v7i3.427Keywords:
Human metapneumovirus (hMPV), Acute respiratory tract infections (ARTIs), Bronchiolitis, Wheezy bronchitis, Pneumonitis, RT-PCR, DNA sequence analysis, Phylogenetic analysis, Genotype, Clinical featureAbstract
Background: Human metapneumovirus (hMPV) is a newly discovered emerging virus known to cause acute respiratory tract infections (ARTIs) in children and adults. In particular, hMPV is one of the main viral etiological agents that significantly contribute to development of severe respiratory diseases and pneumonia in children. Objective: To illuminate the virological and clinical features in children with respiratory infections caused by hMPV. Methods: A total of 156 nasopharyngeal aspirate (NPA) samples collected from hospitalized children with acute respiratory tract infections were tested for hMPV by RT-PCR with specific primers to hMPV. In addition to, DNA sequence analysis and Phylogenetic analysis of the specific hMPV amplicons were performed. Results: In RT-PCR with primers targeting the hMPV fusion glycoprotein (F), nucleoprotein (N), and polymerase (L) genes, single and very sharp amplication bands of the expected length of 0.45Kb, 0.16Kb, and 0.17Kb revealized NPA samples. Overall, hMPV was detected in 8 (5.12%) of analized samples. DNA sequence analysis and Phylogenetic analysis of the specific amplicons of hMPV F, N, and L genes revealed that the virus detected by RT-PCR was hMPV A2 genotype with 83.5~100%, 85.7~100%, and 95.7~97.8% sequence similarity, respectively. The mean ages and mean treatment and hospitalization duration of hMPV positive children was 16.1 months and 6.5 days, respectively. The main symptoms of hMPV positive children were fever (100%), cough (87.5%), rhinorrhea (87.5%), sputum (62.5%), sore throat (62.5%), and dyspnea (37.5%), etc. Also, clinical diagnosis of hMPV positive children were pneumonia (50%), acute bronchiolitis (37.5%), and acute wheezing bronchitis (12.5%). Conclusions: The obtained result revealed that our study provides strong support that hMPV infection is an important cause of severe respiratory disease in children, including pneumonia, bronchiolitis, and acute wheezing attacks, strongly suggesting that hMPV A2 genotype is the major genotype to cause acute and severe respiratory disease associated with hMPV infection.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Chang Guk Ri, Yong Chan Sin, Hyok Kim , Yong Chol Pak, Yong Su Song, Sin Hyok Paek , Mi Rae Han, Il Gyong Ri , Yon Hui Ri , Hyon Song Kang, Song Min Jong

This work is licensed under a Creative Commons Attribution 4.0 International License.
In submitting the manuscript to the Medical Science Journal for Advance Research, the authors certify that:
- They are authorized by their co-authors to enter into these arrangements.
- The work described has not been formally published before, except in the form of an abstract or as part of a published lecture, review, thesis, or overlay journal.
- That it is not under consideration for publication elsewhere,
- The publication has been approved by the author(s) and by responsible authorities – tacitly or explicitly – of the institutes where the work has been carried out.
- They secure the right to reproduce any material that has already been published or copyrighted elsewhere.
- They agree to the following license and copyright agreement.
License and Copyright Agreement
Authors who publish with Medical Science Journal for Advance Research agree to the following terms:
- Authors retain copyright and grant the Medical Science Journal for Advance Research right of first publication with the work simultaneously licensed under Creative Commons Attribution License (CC BY 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of the Medical Science Journal for Advance Research published version of the work (e.g., post it to an institutional repository or edit it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) before and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.


















